Phase II trial of gemcitabine, docetaxel, and cetuximab in advanced non-small-cell lung cancer (NSCLC)

被引：1
|
作者：
Rubinsak, J. R.
Spigel, D. R.
Hainsworth, J. D.
Webb, C.
Inhorn, R. C.
Infante, J. R.
Yardley, D. A.
Burris, H. A., III
Vazquez, E. R.
Greco, F. A.
机构：
[1] Florida Canc Specialists, Ft Myers, FL USA
[2] Sarah Cannon Res Inst, Nashville, TN USA
[3] Tennessee Oncol, Nashville, TN USA
[4] Mercy Hosp, Portland, ME USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.19045
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
19045
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase I/II trial of gemcitabine plus docetaxel in advanced non small cell lung cancer (NSCLC)
    Valerie Israel
    Scott T. Tagawa
    Terry Snyder
    Susan Jeffers
    Derek Raghavan
    [J]. Investigational New Drugs, 2004, 22 : 291 - 297
  • [2] Phase I/II trial of gemcitabine plus docetaxel in advanced non small cell lung cancer (NSCLC)
    Israel, V
    Tagawa, ST
    Snyder, T
    Jeffers, S
    Raghavan, D
    [J]. INVESTIGATIONAL NEW DRUGS, 2004, 22 (03) : 291 - 297
  • [3] Phase II Study of Cetuximab, Docetaxel, and Gemcitabine in Patients With Previously Untreated Advanced Non-Small-Cell Lung Cancer
    Spigel, David R.
    Greco, F. Anthony
    Thompson, Dana S.
    Webb, Charles
    Rubinsak, James
    Inhorn, Roger C.
    Reeves, James, Jr.
    Vazquez, Elizabeth R.
    Lane, Cassie M.
    Burris, Howard A., III
    Hainsworth, John D.
    [J]. CLINICAL LUNG CANCER, 2010, 11 (03) : 198 - 203
  • [4] Phase II trial of gemcitabine in advanced non-small-cell lung cancer
    Malayeri, R
    Ulsperger, E
    Baumgartner, G
    Forstner, B
    Aigner, K
    Hubner, M
    Kummer, F
    Krajnik, G
    Zochbauer, S
    Krejcy, K
    Huber, H
    Pirker, R
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 1997, 109 (17) : 688 - 691
  • [5] Vinorelbine-gemcitabine in advanced non-small-cell lung cancer (NSCLC):: An AASLC phase II trial
    Krajnik, G
    Mohn-Staudner, A
    Thaler, J
    Greil, R
    Schmeikal, S
    Marhold, F
    Deutsch, J
    Preiss, P
    Malayeri, R
    Schäfer-Prokop, C
    Wein, W
    Huber, H
    Pirker, R
    [J]. ANNALS OF ONCOLOGY, 2000, 11 (08) : 993 - 998
  • [6] Vinorelbine/gemcitabine in advanced non-small-cell lung cancer (NSCLC): A phase I trial
    Pirker, R
    Krajnik, G
    MohnStaudner, A
    Marhold, F
    Malayeri, R
    Zochbauer, S
    Kummer, F
    Greil, R
    Huber, H
    [J]. EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1139 - 1139
  • [7] Cetuximab in advanced non-small-cell lung cancer (NSCLC)
    Pirker, Robert
    [J]. LUNG CANCER, 2012, 77 : S13 - S14
  • [8] Phase II clinical trial on docetaxel in the treatment of non-small-cell lung cancer (NSCLC).
    Chen, Y
    Zhao, Y
    Chen, Z
    Liao, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 708S - 708S
  • [9] A phase II study of oxaliplatin and docetaxel in patients with advanced non-small-cell lung cancer (NSCLC)
    Raez, L
    Santos, E
    Rocha-Lima, C
    Roman, E
    Kumar, P
    Farfan, N
    Decesare, T
    Lopes, G
    Rosado, M
    Wu, J
    [J]. LUNG CANCER, 2005, 49 : S265 - S265
  • [10] Phase II trial of docetaxel and vinorelbine in patients with advanced non-small-cell lung cancer
    Miller, VA
    Krug, LM
    Ng, KK
    Pizzo, B
    Perez, W
    Heelan, RT
    Kris, MG
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (06) : 1346 - 1350
12345